The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors
BTK 抑制剂 Ibrutinib (PCI-32765) 可克服 ABCB1 和 ABCC10 过表达细胞和肿瘤中的紫杉醇耐药性
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-16-0511
Hui Zhang, Atish Patel, Yi-Jun Wang, Yun-Kai Zhang, Rishil J Kathawala, Long-Hui Qiu, Bhargav A Patel, Li-Hua Huang, Suneet Shukla, Dong-Hua Yang, Suresh V Ambudkar, Li-Wu Fu, Zhe-Sheng Chen